Breathlessness and opioid prescribing in COPD in general practice: a cross-sectional, observational study
Chronic breathlessness is a disabling syndrome, prevalent in people with advanced chronic obstructive pulmonary disease (COPD). Regular, low-dose, oral sustained-release morphine is approved in Australia to reduce symptomatic chronic breathlessness. We aimed to determine the current prescribing patt...
| الحاوية / القاعدة: | ERJ Open Research |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
European Respiratory Society
2020-07-01
|
| الوصول للمادة أونلاين: | http://openres.ersjournals.com/content/6/2/00299-2019.full |
